Long-Term Follow-Up Safety and Efficacy Study in Participants With Duchenne Muscular Dystrophy Who Have Received Fordadistrogene Movaparvovec in a Preceding Clinical Study

Long-Term Follow-Up Safety and Efficacy Study in Participants With Duchenne Muscular Dystrophy Who Have Received Fordadistrogene Movaparvovec in a Preceding Clinical Study zhoum55 Mon, 09/28/2026 - 05:09 PF-06939926 (fordadistrogene movaparvovec) PF-06939926 (fordadistrogene movaparvovec) PHASE III Mon, 03/13/2023 - 12:00 Wed, 09/24/2025 - 12:00 NCT05689164 C3391011 Public Disclosure Synopsis.pdf (140.42 KB) N https://clinicaltrials.gov/study/NCT05689164?term=C3391011&viewType=Card&rank=1 C3391011